Brief: Suven Pharma Sept-Quarter Profit Falls
Oct 30 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* SUVEN PHARMACEUTICALS LTD SEPT-QUARTER CONSOL NET PROFIT
740.8
MILLION RUPEES VERSUS 930 MILLION RUPEES YEAR AGO
* SUVEN PHARMACEUTICALS LTD SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS 2.37 BILLION RUPEES VERSUS 2.73 BILLION RUPEES YEAR
AGO
Source text for Eikon: ID:nBSE2MNCz5
Further company coverage: SUVH.NS
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss